[A new and original therapy for seborrheic dermatitis].
The AA describe the results of an original therapy for seborrhoic dermatitis in both localized and spread forms (Leiner's Disease). Due to similarity of seborrhoic dermatitis in the two forms with acrodermatitis enterophatica and considering that this last disease reacts positively after Zinc administration, the AA stated the validity of such therapy also for seborrhoic dermatitis and discuss its possible mechanism of action.
D000284:Administration, Oral; D000527:Alprostadil / Q000096:biosynthesis; D003182:Complement C5 / Q000276:immunology; D003170:Complement Pathway, Alternative; D012628:Dermatitis, Seborrheic / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D006801:Humans; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000378:metabolism; D013431:Sulfates / Q000008:administration & dosage / Q000627:therapeutic use*; D015032:Zinc / Q000008:administration & dosage / Q000627:therapeutic use*; D019287:Zinc Sulfate
D003182:Complement C5; D008041:Linoleic Acids; D013431:Sulfates; D019287:Zinc Sulfate; D019787:Linoleic Acid; D000527:Alprostadil; D015032:Zinc
Una nuova ed originale terapia della dermatite seborroide.